StocktoriaCDT Equity Inc. CDT
Nasdaq · XNAS · stock · Pharmaceutical Preparations
Chart by TradingView
2/9
Piotroski F — financial health
-93.53
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Financials | ||||
| Operating income | -$36.8M | -$15.4M | -$5.3M | -$3.2M |
| Net income | -$39.2M | -$17.8M | -$535,000 | -$4.9M |
| Operating cash flow | -$15.6M | -$9.7M | -$7.7M | -$2.3M |
| Free cash flow | — | -$9.7M | — | — |
| Total assets | $5.7M | $4.2M | $7.2M | $5,000 |
| Total liabilities | $12.8M | $11.0M | $7.7M | $10.1M |
| Shareholders' equity | -$7.2M | -$6.8M | -$457,000 | -$10.1M |
| Ratios | ||||
| Return on assets | -694.2% | -424.6% | -7.4% | -97740.0% |
| Return on equity | 547.1% | 262.1% | 117.1% | 48.4% |
| Current ratio | 0.34 | 0.25 | 3.18 | 0.15 |
Why these scores methodology →
Piotroski F-score: 2/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -93.53 (distress)
- Working capital / assets -1.494
- Retained earnings / assets -12.093
- EBIT / assets -6.506
- Equity / liabilities -0.559
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001896212 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.